Fig. 1 | Nature Communications

Fig. 1

From: Mineralocorticoid receptor antagonism limits experimental choroidal neovascularization and structural changes associated with neovascular age-related macular degeneration

Fig. 1

Clinical results. a Relative changes in subretinal thickness (SRF, µm) measured with Spectralis OCT during the study period, month 0 (M0) to month 6 (M6). SRF thickness is significantly reduced as compared to M0, at M1 (p = 0.012), M2 (p = 0.040), M3 (p = 0.014), M4 (p = 0.024). b Relative change in central retinal thickness (CRT, µm) automatic values with Spectralis OCT during the study period, month 0 (M0) to month 6 (M6). CRT is significantly reduced as compared to M0, at M3 (p = 0.011), M4 (p = 0.007), and M5 (p = 0.028). At each time point (Month, M), the data have been summarized using box and whisker plots, the upper and lower 95% CIs (confidence interval) are marked with the whiskers, the box represents the interquartile range, and the median is represented by the bold horizontal line bisecting the box. Paired Wilcoxon signed-rank tests were used. *p < 0.05

Back to article page